Vercise Genus Deep Brain Stimulation for Parkinson’s FDA Approved

Boston Scientific has landed FDA clearance for its Vercise Genus Deep Brain Stimulation (DBS) System. This is the fourth generation of the company’s DBS devices, which are designed to have a longer battery life, improved targeting to reduce symptoms, and make programming and management easier.

Vercise Genus devices are avai (Read more...)

Full Story →